Test Your Knowledge on Multiple Endocrine Neoplasia Type 1

['Paul Basilio', '.Wp-Block-Co-Authors-Plus-Coauthors.Is-Layout-Flow', 'Class', 'Wp-Block-Co-Authors-Plus', 'Display Inline', '.Wp-Block-Co-Authors-Plus-Avatar', 'Where Img', 'Height Auto Max-Width', 'Vertical-Align Bottom .Wp-Block-Co-Authors-Plus-Coauthors.Is-Layout-Flow .Wp-Block-Co-Authors-Plus-Avatar', 'Vertical-Align Middle .Wp-Block-Co-Authors-Plus-Avatar Is .Alignleft .Alignright'] Endocrinology Advisor 2025-05-30 13:35:54

Test Your Knowledge Question 1 Which imaging technique is most sensitive for identification of pitNETs among patients with MEN1? The consensus statement indicates that it is advisable to review such cases with a multidisciplinary team. MEN1-associated lung NETs demonstrate benign behavior with limited tumor growth patterns, according to the consensus statement. Routine biochemical and imaging screenings can be extended from 1 to 3 years for asymptomatic patients, according to the consensus statement. American Association of Clinical Endocrinology consensus statement on management of multiple endocrine neoplasia type 1.